Suppr超能文献

单细胞多组学分析揭示肝移植后的动态免疫恢复过程

Dynamic immune recovery process after liver transplantation revealed by single-cell multi-omics analysis.

作者信息

Wang Rui, Peng Xiao, Yuan Yixin, Shi Baojie, Liu Yuan, Ni Hengxiao, Guo Wenzhi, Yang Qiwei, Liu Pingguo, Wang Jie, Su Zhaojie, Yu Shengnan, Liu Dehua, Zhang Jinyan, Xia Junjie, Liu Xueni, Li Hao, Yang Zhengfeng, Peng Zhihai

机构信息

Organ Transplantation Clinical Medical Center of Xiamen University, Department of General Surgery, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361102, China.

Organ Transplantation Institute of Xiamen University, Xiamen Human Organ Transplantation Quality Control Center, Xiamen Key Laboratory of Regeneration Medicine, Fujian Provincial Key Laboratory of Organ and Tissue Regeneration, School of Medicine, Xiamen University, Xiamen 361102, China.

出版信息

Innovation (Camb). 2024 Mar 1;5(3):100599. doi: 10.1016/j.xinn.2024.100599. eCollection 2024 May 6.

Abstract

Elucidating the temporal process of immune remodeling under immunosuppressive treatment after liver transplantation (LT) is critical for precise clinical management strategies. Here, we performed a single-cell multi-omics analysis of peripheral blood mononuclear cells (PBMCs) collected from LT patients (with and without acute cellular rejection [ACR]) at 13 time points. Validation was performed in two independent cohorts with additional LT patients and healthy controls. Our study revealed a four-phase recovery process after LT and delineated changes in immune cell composition, expression programs, and interactions along this process. The intensity of the immune response differs between the ACR and non-ACR patients. Notably, the newly identified inflamed NK cells, CD14RNASE2 monocytes, and FOS-expressing monocytes emerged as predictive indicators of ACR. This study illuminates the longitudinal evolution of the immune cell landscape under tacrolimus-based immunosuppressive treatment during LT recovery, providing a four-phase framework that aids the clinical management of LT patients.

摘要

阐明肝移植(LT)后免疫抑制治疗下免疫重塑的时间进程对于精确的临床管理策略至关重要。在此,我们对从LT患者(有和无急性细胞排斥反应[ACR])在13个时间点收集的外周血单个核细胞(PBMC)进行了单细胞多组学分析。在另外两组独立的LT患者和健康对照队列中进行了验证。我们的研究揭示了LT后的一个四阶段恢复过程,并描绘了在此过程中免疫细胞组成、表达程序和相互作用的变化。ACR患者和非ACR患者的免疫反应强度不同。值得注意的是,新鉴定出的炎症性NK细胞、CD14RNASE2单核细胞和表达FOS的单核细胞成为ACR的预测指标。本研究阐明了LT恢复期间基于他克莫司的免疫抑制治疗下免疫细胞格局的纵向演变,提供了一个有助于LT患者临床管理的四阶段框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf18/10952083/dcb7e84c39c9/fx1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验